Henry Schein, Inc. (HSIC) stock saw a modest uptick, ending the day at $73.22 which represents a slight increase of $1.47 or 2.05% from the prior close of $71.75. The stock opened at $72.23 and ...
With the game of the season just days away, WIVB News 4 Sports Director Josh Reed recently spoke with SiriusXM’s Adam Schein ...
The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical ...
Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Henry Schein (HSIC – Research Report) yesterday and set a price target ...
When you win all of the time, you may start to make some enemies. At the very least, people might start to get a little tired ...
Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...
Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
This was the stock's second consecutive day of losses.
Henry Schein Dental announces the launch of its new UK website, providing customers with a new experience of shopping online.
Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs).